Previous 10 | Next 10 |
Plantronics POLY +49% HP to acquire Poly for $40/share for enhancing Peripherals and workforce solutions businesses. Kaixin Auto KXIN +42% on intention order for 20K electric vehicles. DatChat (DATS) +34% to launch metaverse advertising and NFT monetization platform. ...
TC Biopharm (NASDAQ:TCBP) said it received approvals from the U.K. health agency MHRA, and research ethics committee to begin trials of cell therapy OmnImmune to treat acute myeloid leukemia (AML). The company added that the phase 2/3 trials will begin enrollment in H1 in the U.K.,&...
TC BioPharm Receives MHRA and Research Ethics Committee Approvals to Initiate Phase 2B/3 Clinical Trials for the Treatment of Acute Myeloid Leukemia PR Newswire Trial enrollment expected to begin during the first half of 2022 EDINBURGH, Scotland , ...
Gainers: DiDi Global (DIDI) +54%. Zhihu (ZH) +47%. Lizhi (LIZI) +46%. Kidpik (PIK) +42%. StoneCo (STNE) +41%. Tuya (TUYA) +39%. 111 (YI) +37%. Aesthetic Medical International Holdings (AIH) +36%. Cuentas (CUEN) +38%. Redbox Entertainment (RDBX) +36%. Losers: Ambac Financial Group (AMBC) -22%....
Gainers: BioVie (BIVI) +16%. Progenity (PROG) +16%. Kezar Life Sciences (KZR) +14%. Codiak BioSciences (CDAK) +13%. Ensysce Biosciences (ENSC) +10%. Losers: Nymox Pharmaceutical (NYMX) -29%. HTG Molecular Diagnostics (HTGM) -14%. Zhongchao (ZC...
U.S. Food and Drug Administration (FDA) has granted TC Biopharm (NASDAQ:TCBP) lead product, OmnImmune, orphan drug designation, to treat acute myeloid leukemia (AML). Shares of (TCBP) up 31% at $1.3 in premarket trading. The company said the status was granted after the FDA reviewed...
TC BioPharm Announces FDA Orphan Drug Status Granted for OmnImmune® PR Newswire Allogeneic unmodified Gamma Delta product can be stored frozen and used as an 'off-the-shelf' cell therapy EDINBURGH, Scotland , March 17, 2022 /PRNewswire/ -...
TC Biopharm Updates Intellectual Property Portfolio PR Newswire EDINBURGH, Scotland , March 15, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing ...
Buying Penny Stocks Today? Here’s What You Need to Know Finding the best penny stocks to buy can be tricky. With so much going on in the stock market, it takes a thorough understanding of the current market conditions to make money with penny stocks . But, in no way does this...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rise and shine! It’s time for another breakdown of the biggest pre-market stock movers as we prepare for the opening bell on Wednesday! Source: f11photo/Shutterstock.com News moving stocks this morning includ...
News, Short Squeeze, Breakout and More Instantly...
TC BioPharm (Holdings) plc Company Name:
TCBP Stock Symbol:
NASDAQ Market:
TC BioPharm (Holdings) plc Website:
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia PR Newswire 5 patients treated in "safety cohort" showed no drug related Serious Adverse Events Restart of trial after amendment approved by MHRA to increase dose level ...
TCBP Announces Launch of Compassionate Use Program for TCB008 PR Newswire The Company's lead therapeutic will be available through a newly opened compassionate use program EDINBURGH, Scotland , May 15, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ...
2024-05-07 06:02:00 ET 3 Tips for Buying and Selling Penny Stocks During After Hours Trading penny stocks during after-hours sessions offers unique opportunities for investors seeking to capitalize on market movements outside of standard trading hours. Penny stocks , typically price...